Shares of GlaxoSmithKline climbed in trading on rumors that the consumer health business it intends to spin off into a separate company next year is attracting interest from venture capitalists.

Moderna is seeking to invalidate two patents belonging to Arbutus Biopharma that deal with drug-delivery technology.

Teva Pharmaceutical Industries temporarily halted drug production at the company’s Irvine plant in California to address issues raised by the U.S. Food and Drug Administration after a recent inspection, the company said on Oct. 4.

The U.S. Food and Drug Administration is leaning toward authorizing half-dose booster shots of the Moderna Inc. Covid-19 vaccine, Bloomberg News reported on Sept. 28, citing people familiar with the matter.

U.S. President Joe Biden’s administration ruled out nominating Janet Woodcock as the permanent head of the Food and Drug Administration, Bloomberg News reported on Aug. 19, citing people familiar with the matter.

Moderna Chief Executive Officer Stéphane Bancel sees significant growth opportunities for his company and messenger RNA-based vaccines.

Venture capitalist Chamath Palihapitiya is raising $800 million to finance four more special purpose acquisition companies (SPAC) that will be focused on taking biotech companies public.

Metabolic comorbidities, including obesity and type 2 diabetes increase the risk of morbidity and mortality in patients who contract coronavirus disease 2019 (Covid-19). But findings published in the journal Nature show that not only are patients with diabetes more at risk of more severe outcomes, patients without diabetes who develop Covid-19 may also be at a higher risk of actually developing diabetes following recovery. 

BioNTech SE could have capacity to make 3 billion doses of the Covid-19 vaccine the company developed with partner Pfizer Inc. during 2022, Bloomberg News reported on March 9, citing an interview with the German company’s chief executive officer.

The data continues to come in on the various Covid-19 variants, and so far the news is pretty good, according to BioSpace.